| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443005 | European Journal of Cancer | 2014 | 8 Pages |
Abstract
A minor proportion (10-30%) of NED should not be overlooked in gastric carcinomas with NEM. NED should be carefully evaluated to predict patient outcomes and plan optimal additional therapies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ji Y. Park, Min-Hee Ryu, Young Soo Park, Hye Jin Park, Baek-Yeol Ryoo, Min Gyu Kim, Jeong Hwan Yook, Byung Sik Kim, Yoon-Koo Kang,